HnRNPB1 expression correlates with lung cancer development and siRNA HnRNPB1 knockdown promotes A549 lung cancer cell apoptosis [317], and several potential inhibitory small HnRNPB1 binding molecules have also recently been identified amongst lung cancer drugs [318]. Here, HNRNPA2B1 is linked to lung carcinoma.